Rafaela Durrer Parolina de Carvalho (Rafaela D Parolina de Carvalho)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Biofilm Formation

Replacement Therapy

Staphylococcus Aureus

Cardiovascular Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Romário-Silva, Severino Mathias de Alencar, Bruno Bueno-Silva, Janaína de Cássia Orlandi Sardi, Marcelo Franchin, Rafaela Durrer Parolina de Carvalho, Thayná Ellen de Sousa Alves Ferreira, Pedro Luiz Rosalen
Antimicrobial Activity of Honey against Oral Microorganisms: Current Reality, Methodological Challenges and Solutions. Microorganisms 10 (12) (2022)
Diego Romário-Silva, Severino Mathias de Alencar, Bruno Bueno-Silva, Janaína de Cássia Orlandi Sardi, Marcelo Franchin, Rafaela Durrer Parolina de Carvalho, Thayná Ellen de Sousa Alves Ferreira, Pedro Luiz Rosalen
Antimicrobial Activity of Honey against Oral Microorganisms: Current Reality, Methodological Challenges and Solutions. Microorganisms 10 (12) (2022)
Diego Romário-Silva, Severino Mathias de Alencar, Bruno Bueno-Silva, Janaína de Cássia Orlandi Sardi, Marcelo Franchin, Rafaela Durrer Parolina de Carvalho, Thayná Ellen de Sousa Alves Ferreira, Pedro Luiz Rosalen
Antimicrobial Activity of Honey against Oral Microorganisms: Current Reality, Methodological Challenges and Solutions. Microorganisms 10 (12) (2022)
Diego Romário-Silva, Severino Mathias de Alencar, Bruno Bueno-Silva, Janaína de Cássia Orlandi Sardi, Marcelo Franchin, Rafaela Durrer Parolina de Carvalho, Thayná Ellen de Sousa Alves Ferreira, Pedro Luiz Rosalen
Antimicrobial Activity of Honey against Oral Microorganisms: Current Reality, Methodological Challenges and Solutions. Microorganisms 10 (12) (2022)
Rafaela Durrer Parolina de Carvalho, Jéssica de Andrade Moreno, Sindy Magri Roque, Daniel Cheuk Hong Chan, Willy Bustillos Torrez, Rafael Nóbrega Stipp, Bruno Bueno-Silva, Patrícia Oliveira de Lima, Karina Cogo-Müller
Statins and oral biofilm: simvastatin as a promising drug to control periodontal dysbiosis. Oral diseases (2022)